Literature DB >> 30894287

Validation of an Magnetic Resonance Imaging Acquisition and Review Protocol for Alzheimer's Disease and Related Disorders.

Alexandre Asselin1, Olivier Potvin2, Louis-Olivier Bouchard1, Mélanie Brisson3, Simon Duchesne4.   

Abstract

PURPOSE: Magnetic resonance imaging (MRI) of the brain allows for the identification of structural lesions typical of Alzheimer's disease (AD), the main cause of dementia. However, to have a clinical impact, it is imperative that acquisition and reporting of this MRI-based evidence be standardized, ensuring the highest possible reliability and reproducibility. Our objective was to validate a systematic radiological MRI acquisition and review process in the context of AD.
METHODS: We included 100 individuals with a suspicion of dementia due to AD for whom MRI were acquired using our proposed protocol of clinically achievable acquisitions and used a unified reading grid to gather semi-quantitative evidence guiding diagnostic. MRIs were read by 3 raters with different experience levels. Interrater reliability was measured using Cohen's kappa statistic.
RESULTS: Interrater reliability average for lesions occupying space, hemorrhage, or ischemia, was respectively 0.754, 0.715, and 0.501. Average reliability of white matter hyperintensity burden (Fazekas), global cortical atrophy, and temporal lobe atrophy (Scheltens) scales was 0.687, 0.473, and 0.621 (right)/0.599 (left), respectively. The kappas for regional cortical atrophy (frontal, parietal, occipital, temporal, and posterior cingulum) varied from 0.281-0.678. The average MRI reading time varied between 1.43-5.22 minutes.
CONCLUSIONS: The presence of space occupying lesions, hemorrhagic or ischemic phenomena, and radiological scales have a good interrater reproducibility in MRI. Coupled with standardized acquisitions, such a protocol should be used when evaluating possible dementias, especially those due to probable AD. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementias; Global cortical atrophy; Magnetic resonance imaging; Medial temporal lobe atrophy; Neurodegeneration; Space occupying lesions; White matter hyperintensity

Mesh:

Year:  2019        PMID: 30894287     DOI: 10.1016/j.carj.2018.10.008

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  2 in total

1.  Aducanumab: Appropriate Use Recommendations Update.

Authors:  J Cummings; G D Rabinovici; A Atri; P Aisen; L G Apostolova; S Hendrix; M Sabbagh; D Selkoe; M Weiner; S Salloway
Journal:  J Prev Alzheimers Dis       Date:  2022

2.  Automated age- and sex-specific volumetric estimation of regional brain atrophy: workflow and feasibility.

Authors:  Julian Caspers; Adrian Heeger; Bernd Turowski; Christian Rubbert
Journal:  Eur Radiol       Date:  2020-08-27       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.